Preferred Label : Cholestasis, benign recurrent intrahepatic, 1;
Symbol : BRIC1;
CISMeF acronym : BRIC1;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Summerskill syndrome;
Description : Benign recurrent intrahepatic cholestasis is characterized by intermittent episodes
of cholestasis without extrahepatic bile duct obstruction. There is initial elevation
of serum bile acids, followed by cholestatic jaundice which generally spontaneously
resolves after periods of weeks to months (Summerskill and Walshe, 1959; Schapiro
and Isselbacher, 1963; Brenard et al., 1989). Tygstrup et al. (1999) stated that referring
to this disorder as 'benign' is a misnomer, because the disease has an impact on the
quality of life in some patients. They preferred the term 'recurrent familial intrahepatic
cholestasis.' - Genetic Heterogeneity of Benign Recurrent Intrahepatic Cholestasis
See also BRIC2 (605479), caused by mutation in the ABCB11 gene (603201) on chromosome
2q24.;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the ATPase, class I, type 8B, member 1 gene (ATP8B1, 602397.0006);
Laboratory abnormalities : Normal or mildly increased serum gamma-GGT (231950); Conjugated hyperbilirubinemia; Increased serum bile acids;
Prefixed ID : #243300;
Origin ID : 243300;
UMLS CUI : C4551899;
Automatic exact mappings (from CISMeF team)
Broader ORDO disease(s)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT